4//SEC Filing
Davis Blaine 4
Accession 0001453687-23-000089
CIK 0001453687other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:26 PM ET
Size
5.7 KB
Accession
0001453687-23-000089
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13$0.79/sh−1,250,000$987,500→ 0 totalExercise: $1.27Exp: 2032-11-27→ Common Stock (1,250,000 underlying)
Footnotes (1)
- [F1]This option, which provided for vesting as to 25% on November 28, 2023 with the remainder of the underlying shares vesting in 36 equal monthly installments thereafter, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc., in exchange for a cash payment of $987,500, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0001802188
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:26 PM ET
- Size
- 5.7 KB